Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by theo12on Dec 16, 2019 10:10am

153 Views

Post# 30458924

I don't understand

Good news from TH on the oncology side. I understand that it is only a start within the TH ''pipeline'', but such news for any company would surely bring the SP up at least a bit. But with TH, even when the overall is positive on the sales outlook, and the expectation of good news to come soon, the SP is down. I realy wonder. Is the past history a reason? Or is that TH does'nt know how to market the good news?? Realy what is going on?
In spite of my hopes for a big turnover, It has com to a point that I am happy to see Friday afternoon arrive as I am then sure that the TH SP will not go down foe 2 days.

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute